According to a pan-cancer analysis, RRM2ishighlyexpressed in many cancers, Further experiment has found that RRM2 is significantly upregulated in CRC.RRM2 might serve as a novel potential target for CRC therapy [28]. The gene discussed is RRM2; the disease is colorectal carcinoma.